scieee Science in your language
[en] (orig)

Heterologous Expression of the Nybomycin Gene Cluster from the Marine StrainStreptomyces albus subsp. NRRL B-24108.

Abstract

Streptomycetes represent an important reservoir of active secondary metabolites with potential applications in the pharmaceutical industry. The gene clusters responsible for their production are often cryptic under laboratory growth conditions. Characterization of these clusters is therefore essential for the discovery of new microbial pharmaceutical drugs. Here, we report the identification of the previously uncharacterized nybomycin gene cluster from the marine actinomycete

Read accessible full text

Heterologous Expression of the Nybomycin Gene Cluster from the Marine StrainStreptomyces albus subsp. NRRL B-24108.

Author: Rodríguez Estévez, Marta,Myronovskyi, Maksym,Gummerlich, Nils,Nadmid, Suvd,Luzhetskyy, Andriy N
Publisher: MPDI
Year: 2018
Source: https://repository.helmholtz-hzi.de/bitstream/10033/621609/1/Rodr%c3%adguez%20Est%c3%a9vez%20et%20al.pdf
ma ine d ugs
Communica ion
He e ologous Exp ession o he Nybomycin Gene
Clus e om he Ma ine S ain S ep omyces albus
subsp. chlo inus NRRL B-24108
Ma a Rod íguez Es é ez 1, Maksym My ono skyi 1, Nils Gumme lich 1,
Su d Nadmid 1and And iy Luzhe skyy 1,2,*
1Pha mazeu ische Bio echnologie, Uni e si ä des Saa landes, 66123 Saa b ücken, Ge many;
[email p o ec ed] (M.R.E.); m.my [email p o ec ed] (M.M.);
[email p o ec ed] (N.G.); [email p o ec ed] (S.N.)
2Helmhol z-Ins i u ü Pha mazeu ische Fo schung Saa land, 66123 Saa b ücken, Ge many
*Co espondence: [email p o ec ed]; Tel.: +49-0681-70223
Recei ed: 5 Oc obe 2018; Accep ed: 31 Oc obe 2018; Published: 4 No embe 2018


Abs ac :
S ep omyce es ep esen an impo an ese oi o ac i e seconda y me aboli es wi h
po en ial applica ions in he pha maceu ical indus y. The gene clus e s esponsible o hei
p oduc ion a e o en c yp ic unde labo a o y g ow h condi ions. Cha ac e iza ion o hese clus e s
is he e o e essen ial o he disco e y o new mic obial pha maceu ical d ugs. He e, we epo he
iden i ica ion o he p e iously uncha ac e ized nybomycin gene clus e om he ma ine ac inomyce e
S ep omyces albus subsp. chlo inus h ough i s he e ologous exp ession. Nybomycin has p e iously
been epo ed o ac agains quinolone- esis an S aphylococcus au eus s ains ha bo ing a mu a ed
gy A gene bu no agains hose wi h in ac gy A. The nybomycin- esis an mu an s gene a ed om
quinolone- esis an mu an s ha e been epo ed o be caused by a back-mu a ion in he gy A gene ha
es o es suscep ibili y o quinolones. On he basis o gene unc ion assignmen om bioin o ma ics
analysis, we sugges a model o nybomycin biosyn hesis.
Keywo ds:
s ep omyce es; seconda y me aboli es; nybomycin gene clus e ; he e ologous exp ession;
nybomycin biosyn hesis
1. In oduc ion
Ac inobac e ia ep esen a p ominen sou ce o na u al p oduc s wi h po en ial indus ial
applica ions. The genus S ep omyces is especially well known o p oduce a di e se spec um o
compounds wi h an ibac e ial, an i ungal, an i umo and e en insec icide and he bicide ac i i y [
1
–
3
].
The inc easing amoun o sequenced mic obial genomes has p o ided insigh in o he unp eceden ed
po en ial o ac inobac e ia o biosyn hesize na u al p oduc s [
4
,
5
]. Gene ally, dozens o a ious
seconda y me aboli e clus e s a e encoded in hei genomes. Howe e , hese clus e s a e o en
poo ly exp essed unde s anda d cul i a ion condi ions o e en emain silen , hus p e en ing
he isola ion and cha ac e iza ion o he encoded compounds. Such uncha ac e ized clus e s
wi h unknown biosyn he ic p oduc s a e usually ega ded as c yp ic. Di e en app oaches can
be used o cha ac e ize c yp ic clus e s, including changing cul i a ion pa ame e s (OSMAC
app oach), exp ession o pleio opic egula o y genes, in oduc ion o an ibio ic- esis an mu a ions,
and e ac o ing o he biosyn he ic pa hways [
6
–
9
]. Cu en ly, cha ac e iza ion o he c yp ic gene
clus e s encoding na u al p oduc s o en elies on exp ession o hei biosyn he ic pa hways in
he op imized su oga e s ains called he e ologous hos s o chassis s ains. The he e ologous
exp ession app oach has a numbe o ad an ages compa ed o o he clus e cha ac e iza ion me hods.
The simpli ied me abolic backg ound o he chassis s ains acili a es he iden i ica ion o na u al
Ma . D ugs 2018,16, 435; doi:10.3390/md16110435 www.mdpi.com/jou nal/ma ined ugs
Ma . D ugs 2018,16, 435 2 o 10
p oduc s; as DNA- ecombinee ing me hods in E. coli and DNA ans e me hods in o s ep omyce es
simpli y biosyn he ic s udies, and high p oduc ion yields enable p oduc supply o s uc u e
elucida ion and biological ac i i y s udies.
In his s udy, we epo he iden i ica ion and cha ac e iza ion o he p e iously uncha ac e ized
nybomycin gene clus e om he ma ine s ain S ep omyces albus subsp. chlo inus NRRL B-24108
h ough he e ologous exp ession in S ep omyces albus Del14. Nybomycin was i s isola ed in 1955;
howe e , he unique biological ac i i y o he an ibio ic was disco e ed only ecen ly [
10
]. Nybomycin
inhibi s g ow h o quinolone- esis an S aphylococcus au eus by a ge ing he mu a ed enzyme gy ase.
In e es ingly, he in ac gy ase encoded by he gy A gene wi hou he esis ance mu a ion is no
inhibi ed by he an ibio ic. The a e nybomycin- esis an mu an s de i ed om quinolone- esis an
S. au eus ha e all been epo ed o con ain he e e se mu a ion in he gy A gene, causing loss o
quinolone esis ance. Despi e his in e es ing mode o ac ion, he biosyn he ic gene clus e leading
o nybomycin p oduc ion emains unknown. Based on he clus e analysis, we also p opose he
biosyn he ic ou e leading o he p oduc ion o nybomycin.
2. Resul s
Iden i ica ion o he Nybomycin Gene Clus e h ough I s He e ologous Exp ession
In he cou se o sys ema ic ac i a ion o c yp ic seconda y me aboli e clus e s om S ep omyces
albus subsp. chlo inus NRRL B-24108 [
3
], a clus e anno a ed by he an iSMASH genome mining
so wa e [
11
] as “ a y acid me abolism clus e ” was exp essed in he he e ologous hos s ains. Fo his
pu pose, a BAC 4N24 con aining he clus e was isola ed om he p e iously cons uc ed genomic
lib a y o S. albus subsp. chlo inus and ans e ed in o S ep omyces albus Del14 and S ep omyces li idans
TK24 [
12
,
13
]. The ob ained exconjugan s ains S ep omyces albus 4N24 and S ep omyces li idans 4N24
as well as he co esponding con ol s ains wi hou he BAC S. albus Del14 and S. li idans TK24
we e e men ed in he p oduc ion medium. LC-MS analysis o he exconjugan s ains con aining
he he e ologous clus e con i med i s success ul exp ession in S. albus 4N24, as indica ed by a new
peak ha was obse ed in he ex ac o he s ain (Figu e 1A,B and Figu e S1). Exp ession o he
clus e in S. li idans 4N24 did no lead o he p oduc ion o any new compounds compa ed wi h he
con ol s ain.
Ma . D ugs 2018, 16, x FOR PEER REVIEW 2 o 10
na u al p oduc s; as DNA- ecombinee ing me hods in E. coli and DNA ans e me hods in o
s ep omyce es simpli y biosyn he ic s udies, and high p oduc ion yields enable p oduc supply o
s uc u e elucida ion and biological ac i i y s udies.
In his s udy, we epo he iden i ica ion and cha ac e iza ion o he p e iously
uncha ac e ized nybomycin gene clus e om he ma ine s ain S ep omyces albus subsp. chlo inus
NRRL B-24108 h ough he e ologous exp ession in S ep omyces albus Del14. Nybomycin was i s
isola ed in 1955; howe e , he unique biological ac i i y o he an ibio ic was disco e ed only
ecen ly [10]. Nybomycin inhibi s g ow h o quinolone- esis an S aphylococcus au eus by a ge ing
he mu a ed enzyme gy ase. In e es ingly, he in ac gy ase encoded by he gy A gene wi hou he
esis ance mu a ion is no inhibi ed by he an ibio ic. The a e nybomycin- esis an mu an s de i ed
om quinolone- esis an S. au eus ha e all been epo ed o con ain he e e se mu a ion in he gy A
gene, causing loss o quinolone esis ance. Despi e his in e es ing mode o ac ion, he biosyn he ic
gene clus e leading o nybomycin p oduc ion emains unknown. Based on he clus e analysis, we
also p opose he biosyn he ic ou e leading o he p oduc ion o nybomycin.
2. Resul s
Iden i ica ion o he Nybomycin Gene Clus e h ough I s He e ologous Exp ession
In he cou se o sys ema ic ac i a ion o c yp ic seconda y me aboli e clus e s om S ep omyces
albus subsp. chlo inus NRRL B-24108 [3], a clus e anno a ed by he an iSMASH genome mining
so wa e [11] as “ a y acid me abolism clus e ” was exp essed in he he e ologous hos s ains. Fo
his pu pose, a BAC 4N24 con aining he clus e was isola ed om he p e iously cons uc ed
genomic lib a y o S. albus subsp. chlo inus and ans e ed in o S ep omyces albus Del14 and
S ep omyces li idans TK24 [12,13]. The ob ained exconjugan s ains S ep omyces albus 4N24 and
S ep omyces li idans 4N24 as well as he co esponding con ol s ains wi hou he BAC S. albus
Del14 and S. li idans TK24 we e e men ed in he p oduc ion medium. LC-MS analysis o he
exconjugan s ains con aining he he e ologous clus e con i med i s success ul exp ession in
S. albus 4N24, as indica ed by a new peak ha was obse ed in he ex ac o he s ain (Figu es 1A,B
and S1). Exp ession o he clus e in S. li idans 4N24 did no lead o he p oduc ion o any new
compounds compa ed wi h he con ol s ain.
Figu e 1. LC-MS ch oma og ams o c ude ex ac s om S. albus 4N24 and S. albus Del14. The new
peak ound in S. albus 4N24 c ude ex ac is indica ed wi h an as e isk (*). (A) Base peak
ch oma og ams; (B) ex ac ed ion ch oma og ams (299.10 ± 0.1 Da); (C) mass spec um associa ed o
R = 4.7 min om S. albus 4N24 LC-MS ch oma og am.
Figu e 1.
LC-MS ch oma og ams o c ude ex ac s om S. albus 4N24 and S. albus Del14. The new peak
ound in S. albus 4N24 c ude ex ac is indica ed wi h an as e isk (*). (
A
) Base peak ch oma og ams;
(
B
) ex ac ed ion ch oma og ams (299.10
±
0.1 Da); (
C
) mass spec um associa ed o
R
= 4.7 min om
S. albus 4N24 LC-MS ch oma og am.
Ma . D ugs 2018,16, 435 3 o 10
Analysis o he S. albus 4N24 ex ac by high- esolu ion MS analysis e ealed ha he iden i ied
peak co esponded o he compound wi h an [M + H]
+
o 299.102 m/zand he deduced molecula
o mula C
16
H
15
N
2
O
4
(Figu e 1C). A sea ch in a na u al p oduc da abase e ealed ha he iden i ied
compound migh co espond o he an ibio ic nybomycin (Figu e 2). To e i y his, a nybomycin
s anda d (San a C uz Bio echnology, Inc., Dallas, TX, USA) was used. LC-MS analysis o he pu e
nybomycin, he S. albus 4N24 ex ac , and he S. albus 4N24 ex ac spiked wi h pu e nybomycin
con i med ha he new compound co esponded o nybomycin; he e en ion ime and he mass
spec um o he new compound we e iden ical o hose o he pu e s anda d (Figu e S2). Addi ionally,
o alida e he iden i y o he de ec ed compound as nybomycin, he o me was pu i ied. Fo his
pu pose, S. albus 4N24 was inocula ed in o 10 L o DNPM medium, and he cul u e b o h o he s ain
was ex ac ed wi h e hyl ace a e. The compound was pu i ied om he ex ac using no mal-phase,
size-exclusion, and e e se-phase ch oma og aphy. The pu i ied compound, as well as he pu e
nybomycin s anda d, was used o NMR measu emen s. The eco ded
1
H-NMR spec a o he pu i ied
compound and o nybomycin we e iden ical (Table S1; Figu e S3), which unambiguously p o ed he
iden i y o he o me as nybomycin.
Ma . D ugs 2018, 16, x FOR PEER REVIEW 3 o 10
Analysis o he S. albus 4N24 ex ac by high- esolu ion MS analysis e ealed ha he iden i ied
peak co esponded o he compound wi h an [M + H]+ o 299.102 m/z and he deduced molecula
o mula C16H15N2O4 (Figu e 1C). A sea ch in a na u al p oduc da abase e ealed ha he iden i ied
compound migh co espond o he an ibio ic nybomycin (Figu e 2). To e i y his, a nybomycin
s anda d (San a C uz Bio echnology, Inc., Dallas, TX, USA) was used. LC-MS analysis o he pu e
nybomycin, he S. albus 4N24 ex ac , and he S. albus 4N24 ex ac spiked wi h pu e nybomycin
con i med ha he new compound co esponded o nybomycin; he e en ion ime and he mass
spec um o he new compound we e iden ical o hose o he pu e s anda d (Figu e S2).
Addi ionally, o alida e he iden i y o he de ec ed compound as nybomycin, he o me was
pu i ied. Fo his pu pose, S. albus 4N24 was inocula ed in o 10 L o DNPM medium, and he cul u e
b o h o he s ain was ex ac ed wi h e hyl ace a e. The compound was pu i ied om he ex ac
using no mal-phase, size-exclusion, and e e se-phase ch oma og aphy. The pu i ied compound, as
well as he pu e nybomycin s anda d, was used o NMR measu emen s. The eco ded 1H-NMR
spec a o he pu i ied compound and o nybomycin we e iden ical (Table S1; Figu e S3), which
unambiguously p o ed he iden i y o he o me as nybomycin.
Figu e 2. Chemical s uc u es o nybomycin, s ep onig in, and 4-aminoan h anilic acid. The
common co e s uc u e o nybomycin and s ep onig in a e highligh ed in ed.
BAC 4N24, which con ains he nybomycin biosyn he ic genes, comp ises a 36 kb genomic DNA
egion wi h 33 open eading ames (Figu e 3, Table 1). A sequence simila i y sea ch e ealed ha
nine open eading ames wi hin his egion sha ed homology a he p o ein le el wi h he genes
in ol ed in he biosyn hesis o s ep onig in, which is s uc u ally ela ed o nybomycin (Figu e 2).
Sequence analysis o he DNA agmen cloned in BAC 4N24 e ealed he pu a i e
s ep omycin- esis an gene, a hypo he ical gene, a gene encoding an ATP-binding p o ein, and ou
addi ional hypo he ical genes ollowed by he nybA gene encoding a pu a i e
3-ca boxy-cis,cis-mucona e cycloisome ase a i s 5’ end (Table 1), which implied ha he nybA gene
migh cons i u e he 5’ end o he nybomycin clus e . The 3’ end o he cloned egion comp ised he
genes encoding a pu a i e me hyl ans e ase, wo isopenicillin N syn hases, a anspo e , h ee
ansc ip ional egula o s, and a hypo he ical p o ein (nybS, nybT, nybU, nybV, nybW, nybX, nybZ,
and nybY, espec i ely). To cla i y whe he hese genes we e pa o he nybomycin biosyn he ic
clus e , wo BACs 4M14 and 6M11 ha pa ially o e lap wi h BAC 4N24 we e isola ed om he
genomic lib a y o S. albus subsp. chlo inus and exp essed in S. albus Del14. Bo h he isola ed 4M14
and 6M11 BACs comple ely co e ed he 5’ end o he agmen cloned in he o iginal BAC 4N24,
which led o nybomycin p oduc ion. Compa ed wi h BAC 4N24, BAC 4M14 lacked he egion
downs eam o he nybR gene, while BAC 6M11 lacked he egion downs eam o he nybL gene
(Figu e 3). The ob ained s ains S. albus 4M14 and S. albus 6M11 we e analyzed oge he wi h S. albus
Figu e 2.
Chemical s uc u es o nybomycin, s ep onig in, and 4-aminoan h anilic acid. The common
co e s uc u e o nybomycin and s ep onig in a e highligh ed in ed.
BAC 4N24, which con ains he nybomycin biosyn he ic genes, comp ises a 36 kb genomic DNA
egion wi h 33 open eading ames (Figu e 3, Table 1). A sequence simila i y sea ch e ealed ha nine
open eading ames wi hin his egion sha ed homology a he p o ein le el wi h he genes in ol ed
in he biosyn hesis o s ep onig in, which is s uc u ally ela ed o nybomycin (Figu e 2). Sequence
analysis o he DNA agmen cloned in BAC 4N24 e ealed he pu a i e s ep omycin- esis an gene,
a hypo he ical gene, a gene encoding an ATP-binding p o ein, and ou addi ional hypo he ical genes
ollowed by he nybA gene encoding a pu a i e 3-ca boxy-cis,cis-mucona e cycloisome ase a i s 5’
end (Table 1), which implied ha he nybA gene migh cons i u e he 5’ end o he nybomycin clus e .
The 3’ end o he cloned egion comp ised he genes encoding a pu a i e me hyl ans e ase, wo
isopenicillin N syn hases, a anspo e , h ee ansc ip ional egula o s, and a hypo he ical p o ein
(nybS,nybT,nybU,nybV,nybW,nybX,nybZ, and nybY, espec i ely). To cla i y whe he hese genes
we e pa o he nybomycin biosyn he ic clus e , wo BACs 4M14 and 6M11 ha pa ially o e lap wi h
BAC 4N24 we e isola ed om he genomic lib a y o S. albus subsp. chlo inus and exp essed in S. albus
Del14. Bo h he isola ed 4M14 and 6M11 BACs comple ely co e ed he 5’ end o he agmen cloned
in he o iginal BAC 4N24, which led o nybomycin p oduc ion. Compa ed wi h BAC 4N24, BAC 4M14
lacked he egion downs eam o he nybR gene, while BAC 6M11 lacked he egion downs eam
o he nybL gene (Figu e 3). The ob ained s ains S. albus 4M14 and S. albus 6M11 we e analyzed
Ma . D ugs 2018,16, 435 4 o 10
oge he wi h S. albus 4N24 o nybomycin p oduc ion. Du ing he LC-MS analysis, no nybomycin was
de ec ed in he ex ac s o ei he he S. albus 4M14 o S. albus 6M11 s ains (Figu e S4). Nybomycin was
eadily de ec able in he ex ac o S. albus 4N24. These esul s gi e e idence ha he 3’- e minal egion
o 4N24, which con ains he genes downs eam o nybR (nybS o nybZ), is essen ial o nybomycin
p oduc ion. Taken oge he , ou esul s sugges ha he genes om nybA o nybZ migh cons i u e he
nybomycin gene clus e , which is u he suppo ed by he ac ha he genes om nybA o nybF and
nybN o nybP sha e high le els o homology wi h genes in he biosyn he ic clus e o s ep onig in
(Table 1), a compound ha is s uc u ally simila o nybomycin (Figu e 2).
Ma . D ugs 2018, 16, x FOR PEER REVIEW 4 o 10
4N24 o nybomycin p oduc ion. Du ing he LC-MS analysis, no nybomycin was de ec ed in he
ex ac s o ei he he S. albus 4M14 o S. albus 6M11 s ains (Figu e S4). Nybomycin was eadily
de ec able in he ex ac o S. albus 4N24. These esul s gi e e idence ha he 3’- e minal egion o
4N24, which con ains he genes downs eam o nybR (nybS o nybZ), is essen ial o nybomycin
p oduc ion. Taken oge he , ou esul s sugges ha he genes om nybA onybZ migh cons i u e
he nybomycin gene clus e , which is u he suppo ed by he ac ha he genes om nybA onybF
and nybN onybP sha e high le els o homology wi h genes in he biosyn he ic clus e o
s ep onig in (Table 1), a compound ha is s uc u ally simila o nybomycin (Figu e 2).
Figu e 3. Nybomycin biosyn he ic gene clus e . Gene ic o ganiza ion is shown. Below, maps o h ee
di e en BAC clones a e displayed: BAC 4N24 con ains he ull sequence o he nybomycin gene
clus e . BAC 4M14 lacks he genes om nybS onybZ; and BAC 6M11 lacks he genes om nybM
onybZ.
Table 1. P oposed unc ions o genes in nybomycin biosyn he ic gene clus e and homology wi h
s ep onig in biosyn he ic genes.
Gene Size
(aa) P oposed Func ion GenBank
homologue 1
Iden i y/
Simila i y (%)
S ep onig in
Gene Clus e
Homologue 2
Iden i y/
Simila i y (%)
o -07 268 S ep omycin
3’’-adenylyl ans e ase WP_037865927.1 71/77 - -
o -06 159 Hypo he ical p o ein WP_027736486.1 86/93 - -
o
-
05
163 ATP-binding p o ein WP_052413949.1 76/83 - -
o -04 332 Hypo he ical p o ein WP_055499466.1 74/82 - -
o -03 341 Hypo he ical p o ein WP_030379123.1 71/80 - -
o
-
02
494 Hypo he ical p o ein WP_078869279.1 70/81 - -
o -01 242 Hypo he ical p o ein - - - -
nybA 475 3-ca boxy-cis,cis-mucona e
cycloisome ase WP_066029238.1 66/85 s nL (AFW04563.1) 71/76
nybB 669 FAD-binding p o ein WP_066029239.1 77/84 s nK1
(AFW04562.1) 66/75
nybC 325 NADPH:quinone educ ase WP_066029240.1 81/87 s nH1
(AFW04558.1) 63/71
nybD 638 An h anila e syn hase WP_079145437.1 81/87 s nM1
(AFW04564.1) 65/75
nybE 227 Isocho isma ase WP_066029243.1 84/89
s nM2
(AFW04565.1) 66/76
nybF 402 DAHP syn hase WP_066029245.1 81/87 s nM3
(AFW04567.1) 62/69
nybG 279 Hypo he ical p o ein - - - -
nybH 257 Vicinal oxygen chela e p o ein WP_066029246.1 64/72 - -
nybI 222 NAD(P)H:dehyd ogenase WP_066029248.1 90/95 - -
nybJ
135 Hypo he ical p o ein WP_066029250.1 76/86 - -
nybK 266 N-ace yl ans e ase WP_066029251.1 80/88 - -
nybL 333 Amidohyd olase WP_066029254.1 84/90 - -
nybM
354 Ace oace yl-CoA syn hase WP_066029256.1 82/87 - -
nybN 182 A oma ase/cyclase WP_066029258.1 78/85 s nI (AFW04559.1) 54/67
nybO 550 Long-chain acyl-CoA syn he ase WP_066029260.1 85/90 s nJ (AFW04560.1) 68/81
nybP 476 Salicyla e hyd oxylase WP_079145438.0 74/79
s nH2
(AFW04561.1) 62/72
nybQ 376 Hypo he ical p o ein WP_030685222.1 57/69 - -
nybR 238 NAD-dependen epime ase WP_066029265.1 82/89 - -
nybS 253 SAM-dependen
me hyl ans e ase WP_079145439.1 89/94 - -
nybT 333 Isopenicillin N syn hase amily
oxygenase WP_078974705.1 80/89 - -
nybU 342 Isopenicillin N syn hase amily
oxygenase WP_078974705.1 72/83 - -
Figu e 3.
Nybomycin biosyn he ic gene clus e . Gene ic o ganiza ion is shown. Below, maps o h ee
di e en BAC clones a e displayed: BAC 4N24 con ains he ull sequence o he nybomycin gene clus e .
BAC 4M14 lacks he genes om nybS o nybZ; and BAC 6M11 lacks he genes om nybM o nybZ.
Table 1.
P oposed unc ions o genes in nybomycin biosyn he ic gene clus e and homology wi h
s ep onig in biosyn he ic genes.
Gene Size (aa) P oposed Func ion GenBank
homologue 1
Iden i y/
Simila i y (%)
S ep onig in Gene
Clus e Homologue 2
Iden i y/
Simila i y (%)
o -07 268 S ep omycin 3”-adenylyl ans e ase WP_037865927.1 71/77 - -
o -06 159 Hypo he ical p o ein WP_027736486.1 86/93 - -
o -05 163 ATP-binding p o ein WP_052413949.1 76/83 - -
o -04 332 Hypo he ical p o ein WP_055499466.1 74/82 - -
o -03 341 Hypo he ical p o ein WP_030379123.1 71/80 - -
o -02 494 Hypo he ical p o ein WP_078869279.1 70/81 - -
o -01 242 Hypo he ical p o ein - - - -
nybA 475 3-ca boxy-cis,cis-mucona e cycloisome ase WP_066029238.1 66/85 s nL (AFW04563.1) 71/76
nybB 669 FAD-binding p o ein WP_066029239.1 77/84 s nK1 (AFW04562.1) 66/75
nybC 325 NADPH:quinone educ ase WP_066029240.1 81/87 s nH1 (AFW04558.1) 63/71
nybD 638 An h anila e syn hase WP_079145437.1 81/87 s nM1 (AFW04564.1) 65/75
nybE 227 Isocho isma ase WP_066029243.1 84/89 s nM2 (AFW04565.1) 66/76
nybF 402 DAHP syn hase WP_066029245.1 81/87 s nM3 (AFW04567.1) 62/69
nybG 279 Hypo he ical p o ein - - - -
nybH 257 Vicinal oxygen chela e p o ein WP_066029246.1 64/72 - -
nybI 222 NAD(P)H:dehyd ogenase WP_066029248.1 90/95 - -
nybJ 135 Hypo he ical p o ein WP_066029250.1 76/86 - -
nybK 266 N-ace yl ans e ase WP_066029251.1 80/88 - -
nybL 333 Amidohyd olase WP_066029254.1 84/90 - -
nybM 354 Ace oace yl-CoA syn hase WP_066029256.1 82/87 - -
nybN 182 A oma ase/cyclase WP_066029258.1 78/85 s nI (AFW04559.1) 54/67
nybO 550 Long-chain acyl-CoA syn he ase WP_066029260.1 85/90 s nJ (AFW04560.1) 68/81
nybP 476 Salicyla e hyd oxylase WP_079145438.0 74/79 s nH2 (AFW04561.1) 62/72
nybQ 376 Hypo he ical p o ein WP_030685222.1 57/69 - -
nybR 238 NAD-dependen epime ase WP_066029265.1 82/89 - -
nybS 253 SAM-dependen me hyl ans e ase WP_079145439.1 89/94 - -
nybT 333 Isopenicillin N syn hase amily oxygenase WP_078974705.1 80/89 - -
nybU 342 Isopenicillin N syn hase amily oxygenase WP_078974705.1 72/83 - -
nybV 495 MFS anspo e WP_079145411.1 81/87 - -
nybW 243 T ansc ip ional egula o WP_079145410.1 82/93 - -
nybX 197 T ansc ip ional egula o WP_025356654.1 89/93 - -
nybY 87 Hypo he ical p o ein WP_086560781.1 68/81 - -
nybZ 219 T ansc ip ional egula o WP_057613815.1 79/86 - -
1NCBI accession numbe s a e gi en. 2NCBI accession numbe s a e shown in pa en heses.
3. Discussion
The an ibio ic nybomycin was disco e ed in 1955 in he cul u e b o h o s ep omyce es A 717 [
14
].
The s uc u al ea u es o nybomycin as a used py idoquinolone ing sys em and an angula ly used
oxazoline ing a e o pa icula biosyn he ic in e es as hey ha e no been epo ed o o he na u al
p oduc s [
15
]. Despi e he unique s uc u e o nybomycin, i s biosyn he ic clus e and biosyn he ic ou e
Ma . D ugs 2018,16, 435 5 o 10
ha e emained elusi e. Only he esul s o eeding s udies imply ha ace a e, me hionine, and some
non-iden i ied shikima e- ype in e media es se e as biosyn he ic p ecu so s o nybomycin [
15
,
16
].
In his a icle, we ha e desc ibed he iden i ica ion o he nybomycin biosyn he ic gene clus e om he
ma ine s ep omyce e S. albus subsp. chlo inus NRRL B-24108 h ough i s exp ession in he clus e - ee
he e ologous hos S. albus Del14.
Sequence analysis o he DNA agmen cloned in BAC 4N24 has e ealed ha a numbe o
genes wi hin his agmen a e highly homologous o he genes in ol ed in biosyn hesis o he
an ibio ic s ep onig in (Table 1) [
17
]. Di ec compa ison o nybomycin and s ep onig in has shown
dis inc s uc u al simila i y, wi h bo h s uc u es con aining a diamino-subs i u ed, six-membe ed
ing (Figu e 2). The s uc u al simila i y and he pa ial homology o he gene clus e s sugges ha
nybomycin and s ep onig in biosyn he ic ou es can ha e some simila biosyn he ic in e media es
and enzyma ic eac ions.
Based on he sequence analysis and he esul s o BAC exp ession, we p opose ha he genes
nybA o nybZ cons i u e he nybomycin gene clus e . The nybA gene, encoding a pu a i e 3-ca boxy-cis,
cis-mucona e cycloisome ase, is homologous o he s ep onig in biosyn he ic gene s nL. The nybZ gene
encodes a pu a i e ansc ip ional egula o ha migh also pa icipa e in nybomycin biosyn hesis.
Simila o he s ep onig in pa hway, he 3-deoxy-D-a abinohep ulosona e 7-phospha e (DAHP)
syn hase encoded by nybF is likely o ca alyze he i s eac ion in he nybomycin biosyn he ic
ou e. DAHP syn hase is esponsible o he i s eac ion o he shikima e pa hway—biosyn hesis o
3-deoxy-D-a abino-hep -2-ulosona e 7-phospha e (DAHP) om phosphoenolpy u a e and D-e y h ose
4-phospha e (Figu e 4) which is suppo ed by he esul s o eeding expe imen s ha ha e
demons a ed ha he ca bons o he cen al ing o nybomycin a e de i ed om a shikima e- ype
in e media e [
15
]. Ca alyzing he i s eac ion, DAHP syn hase egula es he amoun o ca bon
en e ing he shikima e pa hway and he e o e can be esponsible o i s up egula ion o p o ide
su icien amoun s o biosyn he ic p ecu so s o nybomycin. The genes encoding enzymes esponsible
o he con e sion o DAHP in o cho isma e a e absen in he nybomycin clus e and in he
s ep onig in pa hway [
17
]. The e o e, he hos ’s p ima y me abolism enzymes mos likely o e ake
hese biosyn he ic s eps. We p opose ha he second eac ion ca alyzed by he enzymes encoded
in he biosyn he ic clus e is he con e sion o cho isma e in o 4-aminoan h anilic acid (Figu e 4),
which is a key in e media e in bo h nybomycin and s ep onig in biosyn hesis (Figu e 2). Isola ion o
4-aminoan h anilic acid om he cul u e b o h o he s ep onig in p oduce S ep omyces locculus
suppo s his sugges ion [
18
]. Fu he mo e, 4-aminoan h anilic acid has also been shown o inco po a e
in o s ep onig in [
18
]. We p opose ha he p oduc s o he nybC,nybD,nybE, and nybL genes
migh be esponsible o he con e sion o cho isma e in o 4-aminoan h anilic acid. The nybL
gene, encoding pu a i e amidohyd olase [
19
], has no homologue in he s ep onig in biosyn he ic
pa hway. We sugges ha he p o ein p oduc o nybL may p o ide enough supply o ammonia o
he amina ion o cho isma e by an h anila e syn hase [
20
], encoded by nybD, du ing he biosyn hesis
o 4-aminoan h anilic acid. In he s ep onig in biosyn hesis, he unc ion o he nybL gene may be
o e aken by he one o he hos ’s p ima y me abolism enzymes.
A e o ma ion o 4-aminoan h anilic acid, i is hen hyd oxyla ed in he hi d posi ion and
deca boxyla ed, gene a ing 2,6-diaminophenol (Figu e 4). The nybP gene encoding pu a i e salicyla e
hyd oxylase migh be esponsible o he hyd oxyla ion eac ion. Then, wo ace oace a e uni s a e
a ached o he amino g oups o 2,6-diaminophenol h ough he ac ion o he N-ace yl ans e ase
encoded by he nybK gene (Figu e 4). The pu a i e ace oace yl-CoA syn hase encoded by he nybM gene
ca alyses he o ma ion o ace oace yl-CoA om ace yl-CoA and malonyl-CoA. The NybM enzyme is
likely esponsible o he p oduc ion o su icien amoun s o ace oace a e, which is used as a p ecu so
in nybomycin biosyn hesis. The p ecu so ole o ace oace a e in nybomycin biosyn hesis is suppo ed
by he esul s o he eeding expe imen s, which ha e unequi ocally de ined ace a e as he sou ce o he
ex e io ca bons o he py idone ings [
16
]. We specula e ha a e a achmen o he ace oace a e uni s,
he pu a i e cyclase encoded by he nybN gene ca alyses he closu e o he py idone ings, leading o

Ma . D ugs 2018,16, 435 6 o 10
o ma ion o in e media e
1
(Figu e 4). The me hyla ion o ni ogen wi hin he py idone ings is likely
o be ca alyzed by he SAM-dependen me hyl ans e ase encoded by nybS. We hypo hesize ha he
nex eac ion in nybomycin biosyn hesis is a closu e o he oxazoline ing (Figu e 4). This s ep migh
be ca alyzed by he p oduc o nybT o nybU, which code o isopenicillin N syn hases (IPNS). IPNS is
esponsible o he biosyn hesis o isopenicillin N h ough a bicycliza ion eac ion— i s , he o ma ion
o a C-N bond gene a es a
β
-lac am ing; hen, he closu e o a i e-membe ed hiazolidine ing is
accomplished by he o ma ion o a C-S bond [
21
]. Sul u and oxygen ha e simila p ope ies [
22
].
The e o e, in a simila way o hiazolidine ing closu e, IPNS could be able o ca alyze he o ma ion o
a C-O bond be ween he ca bon a om o he N-me hyl g oup and he oxygen a om o he OH g oup
p esen in in e media e
2
, gene a ing an oxazoline ing (Figu e 4). Finally, a hyd oxyla ion eac ion
akes place a C-8’, possibly ca alyzed by he oxido educ ase NybB, gi ing ise o nybomycin inal
s uc u e. The compound is hen sec e ed o he ex acellula space, mos likely by he memb ane
anspo e encoded by nybV. Exp ession o seconda y me aboli e biosyn hesis genes is commonly
egula ed by ac i a o s and ep esso s coded by genes ha a e loca ed wi hin he same clus e .
We hypo hesize ha he p oduc s o nybW,nybX, and nybZ, which encode pu a i e ansc ip ional
egula o s, migh con ol he exp ession o he genes in ol ed in nybomycin biosyn hesis.
Ma . D ugs 2018, 16, x FOR PEER REVIEW 7 o 10
Figu e 4. P oposed biosyn he ic pa hway o nybomycin.
4. Ma e ials and Me hods
4.1. Gene al Expe imen al P ocedu es
All s ains and BACs used in his wo k a e lis ed in Table S2. Esche ichia coli s ains we e
cul u ed in LB medium [24]. S ep omyces s ains we e g own on soya lou manni ol aga (MS aga )
[25] o spo ula ion and conjuga ion and in liquid yp ic soy b o h (TSB; Sigma-Ald ich, S . Louis,
MO, USA). Fo seconda y me aboli e exp ession, liquid DNPM medium (40 g/L dex in, 7.5 g/L
soy one, 5 g/L baking yeas , and 21 g/L MOPS, pH 6.8) was used. The an ibio ics kanamycin,
ap amycin and nalidixic acid we e supplemen ed when equi ed.
4.2. Isola ion and Manipula ion o DNA
BAC ex ac ion om a S ep omyces albus subsp. chlo inus cons uc ed genomic lib a y (In ac
Genomics, USA), DNA manipula ion, E. coli ans o ma ion, and E. coli/S ep omyces in e gene ic
conjuga ion we e pe o med acco ding o s anda d p o ocols [24–26]. Plasmid DNA was pu i ied
wi h he BACMAX™ DNA pu i ica ion ki (Lucigen, Middle on, WI, USA). Res ic ion
Figu e 4. P oposed biosyn he ic pa hway o nybomycin.
Ma . D ugs 2018,16, 435 7 o 10
In his pape we epo he iden i ica ion o he gene clus e encoding p oduc ion o he s uc u ally
unique an ibio ic nybomycin. Biological ac i i y o nybomycin is also o pa icula in e es as i inhibi s
g ow h o quinolone- esis an S aphylococcus au eus, do man Mycobac e ium ube culosis, and o he
G am-posi i e and G am-nega i e bac e ia [
10
,
14
,
23
]. In e es ingly, nybomycin a ge s solely he
mu an , quinolone- esis an DNA gy ase wi h a Se 84Leu subs i u ion, while i is inac i e agains he
wild- ype, quinolone-sensi i e o m o he enzyme [
10
]. The mu a ion desc ibed hus a o cause
nybomycin esis ance is a e e se Leu84Se mu a ion wi hin he gy A gene ha es o es quinolone
sensi i i y. The iden i ica ion o he nybomycin clus e p esen ed in his pape enables biosyn he ic
s udies o nybomycin p oduc ion, gene a ion o new nybomycin de i a i es, and op imiza ion o
i s p oduc ion as well as a nybomycin supply o u he biological s udies. Toge he , hese wo ks
migh help igh he de elopmen o quinolone esis ance and e i e quinolones as an e ec i e class
o an ibio ics.
4. Ma e ials and Me hods
4.1. Gene al Expe imen al P ocedu es
All s ains and BACs used in his wo k a e lis ed in Table S2. Esche ichia coli s ains we e cul u ed
in LB medium [
24
]. S ep omyces s ains we e g own on soya lou manni ol aga (MS aga ) [
25
] o
spo ula ion and conjuga ion and in liquid yp ic soy b o h (TSB; Sigma-Ald ich, S . Louis, MO, USA).
Fo seconda y me aboli e exp ession, liquid DNPM medium (40 g/L dex in, 7.5 g/L soy one, 5 g/L
baking yeas , and 21 g/L MOPS, pH 6.8) was used. The an ibio ics kanamycin, ap amycin and nalidixic
acid we e supplemen ed when equi ed.
4.2. Isola ion and Manipula ion o DNA
BAC ex ac ion om a S ep omyces albus subsp. chlo inus cons uc ed genomic lib a y
(In ac Genomics, USA), DNA manipula ion, E. coli ans o ma ion, and E. coli/S ep omyces
in e gene ic conjuga ion we e pe o med acco ding o s anda d p o ocols [
24
–
26
]. Plasmid DNA
was pu i ied wi h he BACMAX
™
DNA pu i ica ion ki (Lucigen, Middle on, WI, USA). Res ic ion
endonucleases we e used acco ding o manu ac u e ’s ecommenda ions (New England Biolabs,
Ipswich, MA, USA).
4.3. Me aboli e Ex ac ion and Analysis
S ep omyces s ains we e g own in 10 mL o TSB o 1 day, and 1 mL o each cul u e was used o
inocula e 50 mL o p oduc ion medium. Cul u es we e g own o 7 days a 28
◦
C. Me aboli es we e
ex ac ed wi h e hyl ace a e om he supe na an , e apo a ed, and dissol ed in me hanol. One
µ
L o
each sample was sepa a ed using a Dionex Ul ima e 3000 UPLC (The mo Fishe Scien i ic, Wal ham,
MA, USA), a 10-cm ACQUITY UPLC
®
BEH C18 column, 1.7
µ
m (Wa e s, Mil o d, MA, USA) and a
linea g adien o 0.1% o mic acid solu ion in ace oni ile agains 0.1% o mic acid solu ion in wa e
om 5% o 95% in 18 min a a low a e o 0.6 mL/min. Samples we e analyzed using an amaZon speed
mass spec ome e o maXis high- esolu ion LC-QTOF sys em (B uke , USA). Da a we e collec ed
and analyzed wi h he B uke Compass Da a Analysis so wa e, e sion 4.1 (B uke , Bille ica, MA,
USA). Monoiso opic mass was sea ched in he na u al p oduc da abase DNP (Dic iona y o Na u al
P oduc s [27]).
4.4. Nybomycin Isola ion and 1H-NMR Spec oscopy
S ep omyces albus 4N24 was g own in 30 mL o TSB o 1 day, and 1 mL o he p ecul u e was
used o inocula e 100 lasks con aining 100 mL o DNPM medium. Cul u es we e incuba ed a 28
◦
C
o 7 days. Me aboli es om he supe na an we e ex ac ed as desc ibed abo e. The c ude ex ac
was ac iona ed by no mal phase ch oma og aphy on a p epacked silica ca idge (Bio age, Uppsala,
Sweden) using hexane, dichlo ome hane, e hyl ace a e, and me hanol as he mobile phase. F ac ions
Ma . D ugs 2018,16, 435 8 o 10
con aining nybomycin we e de ec ed by LC-MS analysis. They we e pooled oge he , e apo a ed,
and dissol ed in me hanol. The sample was u he sepa a ed by size-exclusion ch oma og aphy on an
LH 20 Sephadex column (Sigma-Ald ich, USA) using me hanol as he sol en . Finally, he sample was
sepa a ed by semip epa a i e HPLC (Dionex Ul iMa e 3000, The mo Fishe Scien i ic, USA) using a
C18 column (Syne gi 10
µ
m, 250
×
10 mm; Phenomenex, Ascha enbu g, Ge many) and a 0.1% o mic
acid solu ion in ace oni ile as he mobile phase o ob ain nybomycin (0.1 mg). Indi idual peaks we e
collec ed and analyzed by LC-MS as desc ibed abo e. The
1
H-NMR spec a we e eco ded on a B uke
A ance 500 spec ome e (B uke , BioSpin GmbH, Rheins e en, Ge many) a 300 K equipped wi h
a 5 mm BBO p obe using deu e a ed i luo oace ic acid (Deu e o, Kas ellaun, Ge many) as sol en
con aining e ame hylsilane (TMS) as a e e ence. The chemical shi s we e epo ed in pa s pe
million (ppm) ela i e o TMS. All spec a we e eco ded wi h he s anda d
1
H pulse p og am using
128 scans.
4.5. Genome Mining and Bioin o ma ics Analysis
The S. albus subsp. chlo inus genome was sc eened o seconda y me aboli e biosyn he ic gene
clus e s using he an iSMASH [
11
] online ool (h ps://an ismash.seconda yme aboli es.o g/#!/s a )
and he so wa e Geneious 11.0.3 [
28
]. The DNA sequence o he nybomycin gene clus e was deposi ed
in o GenBank unde accession numbe MH924838.
Supplemen a y Ma e ials:
The ollowing a e a ailable online a h p://www.mdpi.com/1660-3397/16/11/435/
s1, Table S1:
1
H-NMR da a o isola ed and s anda d nybomycin; Table S2: Bac e ial s ains and BACs used
in his wo k; Figu e S1: UV ch oma og ams o c ude ex ac s om S. albus 4N24 and S. albus Del14; Figu e S2:
Compa ison o LC-MS ch oma og ams o S ep omyces albus 4N24 c ude ex ac and a nybomycin s anda d;
Figu e S3:
1
H-NMR spec a o a nybomycin s anda d and nybomycin isola ed om S. albus 4N24; Figu e S4:
Ex ac ed ion ch oma og ams o S. albus 4M14, S. albus 6M11, and S. albus 4N24 c ude ex ac s.
Au ho Con ibu ions:
M.R.E., M.M., and A.L. designed expe imen s; M.R.E. pe o med expe imen s; N.G.
pe o med and e alua ed he NMR analysis; S.N. con ibu ed o compound iden i ica ion; M.R.E., M.M., and A.L.
analyzed he da a and w o e he manusc ip ; and all au ho s e iewed he manusc ip .
Funding: This esea ch was unded by he ERC s a ing g an EXPLOGEN o AL, g an numbe 281623.
Con lic s o In e es : The au ho s decla e no con lic o in e es .
Re e ences
1.
Raju, R.; G omyko, O.; And iy, B.; Fedo enko, V.; Luzhe skyy, A.; Mulle , R. Oleamycins A and B:
New an ibac e ial cyclic hexadepsipep ides isola ed om a e es ial S ep omyces sp. J. An ibio .
2014
,67,
339–343. [C ossRe ] [PubMed]
2.
P o aso , E.S.; Axeno -G ibano , D.V.; Rebe s, Y.V.; Voy sekho skaya, I.V.; Toko enko, B.T.; Sha ilina, Z.M.;
Luzhe skyy, A.N.; Timo eye , M.A. The di e si y and an ibio ic p ope ies o ac inobac e ia associa ed wi h
endemic deepwa e amphipods o Lake Baikal. An onie Van Leeuwenhoek
2017
,110, 1593–1611. [C ossRe ]
[PubMed]
3.
Hahn, D.R.; G aupne , P.R.; Chapin, E.; G ay, J.; Heim, D.; Gilbe , J.R.; Ge wick, B.C. Albucidin: A no el
bleaching he bicide om S ep omyces albus subsp. chlo inus NRRL B-24108. J. An ibio .
2009
,62, 191–194.
[C ossRe ] [PubMed]
4.
Iqbal, H.A.; Low-Beina , L.; Obiajulu, J.U.; B ady, S.F. Na u al p oduc disco e y h ough imp o ed
unc ional me agenomics in S ep omyces.J. Am. Chem. Soc. 2016,138, 9341–9344. [C ossRe ] [PubMed]
5.
Paulus, C.; Rebe s, Y.; Toko enko, B.; Nadmid, S.; Te ekho a, L.P.; My ono skyi, M.; Zo che , S.B.; Rucke , C.;
B aig, S.; Zahle , S.; e al. New na u al p oduc s iden i ied by combined genomics-me abolomics p o iling o
ma ine S ep omyces sp. MP131-18. Sci. Rep. 2017,7, 42382. [C ossRe ] [PubMed]
6.
English, A.L.; Bou idi, A.; Quinn, R.J.; Ku boke, D.I. E alua ion o e men a ion condi ions igge ing
inc eased an ibac e ial ac i i y om a nea -sho e ma ine in e idal en i onmen -associa ed S ep omyces
species. Syn h. Sys . Bio echnol. 2017,2, 28–38. [C ossRe ] [PubMed]
Ma . D ugs 2018,16, 435 9 o 10
7.
McKenzie, N.L.; Thake , M.; Ko e a, K.; Hughes, D.W.; W igh , G.D.; Nodwell, J.R. Induc ion o an imic obial
ac i i ies in he e ologous s ep omyce es using alleles o he S ep omyces coelicolo gene absA1.J. An ibio .
2010,63, 177–182. [C ossRe ] [PubMed]
8.
Shima, J.; Heske h, A.; Okamo o, S.; Kawamo o, S.; Ochi, K. Induc ion o ac ino hodin p oduc ion by psL
(encoding ibosomal p o ein S12) mu a ions ha con e s ep omycin esis ance in S ep omyces li idans and
S ep omyces coelicolo A3(2). J. Bac e iol. 1996,178, 7276–7284. [C ossRe ] [PubMed]
9.
Olano, C.; Ga cia, I.; Gonzalez, A.; Rod iguez, M.; Rozas, D.; Rubio, J.; Sanchez-Hidalgo, M.; B ana, A.F.;
Mendez, C.; Salas, J.A. Ac i a ion and iden i ica ion o i e clus e s o seconda y me aboli es in
S ep omyces albus J1074. Mic ob. Bio echnol. 2014,7, 242–256. [C ossRe ] [PubMed]
10.
Hi ama su, K.; Iga ashi, M.; Mo imo o, Y.; Baba, T.; Umeki a, M.; Akama su, Y. Cu ing bac e ia o an ibio ic
esis ance: Re e se an ibio ics, a no el class o an ibio ics in na u e. In . J. An imic ob. Agen s
2012
,39,
478–485. [C ossRe ] [PubMed]
11.
Webe , T.; Blin, K.; Duddela, S.; K ug, D.; Kim, H.U.; B uccole i, R.; Lee, S.Y.; Fischbach, M.A.; Mulle , R.;
Wohlleben, W.; e al. an iSMASH 3.0-a comp ehensi e esou ce o he genome mining o biosyn he ic gene
clus e s. Nucleic Acids Res. 2015,43, W237–W243. [C ossRe ] [PubMed]
12.
My ono skyi, M.; Rosenk änze , B.; Nadmid, S.; Pujic, P.; No mand, P.; Luzhe skyy, A. Gene a ion o a
clus e - ee S ep omyces albus chassis s ains o imp o ed he e ologous exp ession o seconda y me aboli e
clus e s. Me ab. Eng. 2018. [C ossRe ] [PubMed]
13.
Rücke , C.; Albe smeie , A.; Busche, T.; Jaenicke, S.; Winkle , A.; F ie hjonsson, O.H.; H egg ie hsson, G.O.;
Lambe , C.; Badcock, D.; Be nae s, K.; e al. Comple e genome sequence o S ep omyces li idans TK24.
J. Bio echnol. 2015,199, 21–22. [C ossRe ] [PubMed]
14.
S eli z, F.; Flon, H.; Ashesho , I.N. Nybomycin, a new an ibio ic wi h an iphage and an ibac e ial p ope ies.
P oc. Na l. Acad. Sci. USA 1955,41, 620–624. [C ossRe ] [PubMed]
15.
Nadzan, A.M.; Rineha , K.L., J . Le e : Nybomycin. 8. Biosyn he ic o igin o he cen al ing ca bons
s udied by 13C-labeled subs a es. J. Am. Chem. Soc. 1976,98, 5012–5014. [C ossRe ] [PubMed]
16.
Knöll, W.M.J.; Hux able, R.J.; Rineha , K.L., J . Nybomycin. VI. Inco po a ion o ace a e-
13
C, ace a e-
14
C,
and me hionine-14C. J. Am. Chem. Soc. 1973,95, 2703–2705. [C ossRe ] [PubMed]
17.
Xu, F.; Kong, D.; He, X.; Zhang, Z.; Han, M.; Xie, X.; Wang, P.; Cheng, H.; Tao, M.; Zhang, L.; e al.
Cha ac e iza ion o s ep onig in biosyn hesis e eals a c yp ic ca boxyl me hyla ion and an unusual
oxida i e clea age o a N-C bond. J. Am. Chem. Soc. 2013,135, 1739–1748. [C ossRe ] [PubMed]
18.
Gould, S.J.; E ickson, W.R. Isola ion o 4-aminoan h anilic acid: A new shikima e pa hway p oduc om
S ep omyces locculus.J. An ibio . 1988,41, 688–689. [C ossRe ] [PubMed]
19.
Tami , H.; S ini asan, P.R. S udies o he mechanism o an h anila e syn hase eac ion. P oc. Na l. Acad.
Sci. USA 1970,66, 547–551. [C ossRe ] [PubMed]
20.
Seibe , C.M.; Raushel, F.M. S uc u al and ca aly ic di e si y wi hin he amidohyd olase supe amily.
Biochemis y 2005,44, 6383–6391. [C ossRe ] [PubMed]
21.
Roach, P.L.; Cli on, I.J.; Hensgens, C.M.; Shiba a, N.; Scho ield, C.J.; Hajdu, J.; Baldwin, J.E. S uc u e o
isopenicillin N syn hase complexed wi h subs a e and he mechanism o penicillin o ma ion. Na u e
1997
,
387, 827–830. [C ossRe ] [PubMed]
22. C emlyn, R.J. An In oduc ion o O ganosul u Chemis y; John Wiley and Sons: Chiches e , UK, 1996.
23.
A ai, M.; Kamiya, K.; P uksako n, P.; Sumii, Y.; Ko oku, N.; Joube , J.P.; Moodley, P.; Han, C.; Shin, D.;
Kobayashi, M. An i-do man mycobac e ial ac i i y and a ge analysis o nybomycin p oduced by a
ma ine-de i ed S ep omyces sp. Bioo g. Med. Chem. 2015,23, 3534–3541. [C ossRe ] [PubMed]
24.
G een, M.R.; Samb ook, J. Molecula Cloning: A Labo a o y Manual, 4 h ed.; Cold Sp ing Ha bo Labo a o y
P ess: Cold Sp ing Ha bo , NY, USA, 2012.
25.
Kiese , T.B.M.J.; Bu ne , M.J.; Cha e , K.F.; Hopwood, D.A. P ac ical S ep omyces Gene ics; John Innes
Founda ion: No wich, UK, 2000.
26.
Rebe s, Y.; Ko manec, J.; Lu zhe skyy, A.; Be nae s, K.; Anne, J. Cloning and exp ession o me agenomic
DNA in S ep omyces li idans and subsequen e men a ion o op imized p oduc ion. In Me agenomics.
Me hods in Molecula Biology; S ei , W., Daniel, R., Eds.; Humana P ess: New Yo k, NY, USA, 2017;
Volume 1539.